China National Biotec Group-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:China National Biotec Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013921
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corp is a manufacturer and distributor of vaccines, therapeutic products and diagnostic reagents. The company develops biological products for disease prevention, therapeutic and diagnostic use. Its products include live vector-based anti-HIV vaccine; hepatitis B vaccine for therapeutic use; shigella conjugate vaccine; and trivalent rotavirus vaccine. It distributes its products through its network of marketing and sales. The company also operates various biological product institutes. CNBG is headquartered in Beijing, China.

China National Biotec Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
China National Biotec Group, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
China National Biotec Group, Medical Devices Deals, 2011 to YTD 2017 9
China National Biotec Group, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
China National Biotec Group, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aeras Enters Into Co-Development Agreement With China National Biotech Group 11
Equity Offering 13
China National Biotech Plans To Complete IPO For US$1.5 Billion 13
Debt Offering 14
China National Biotec Plans Public Offering Of Notes Due 2015 For US$126 Million 14
China National Biotec Group – Key Competitors 15
China National Biotec Group – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
China National Biotec Group, Pharmaceuticals & Healthcare, Key Facts 2
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
China National Biotec Group, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
China National Biotec Group, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
China National Biotec Group, Deals By Therapy Area, 2011 to YTD 2017 8
China National Biotec Group, Medical Devices Deals, 2011 to YTD 2017 9
China National Biotec Group, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aeras Enters Into Co-Development Agreement With China National Biotech Group 11
China National Biotech Plans To Complete IPO For US$1.5 Billion 13
China National Biotec Plans Public Offering Of Notes Due 2015 For US$126 Million 14
China National Biotec Group, Key Competitors 15
China National Biotec Group, Subsidiaries 16

★海外企業調査レポート[China National Biotec Group-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dynatronics Corp (DYNT):医療機器:M&Aディール及び事業提携情報
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and r …
  • China Minsheng Banking Corp Ltd:企業の戦略・SWOT・財務情報
    China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Minsheng Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its c …
  • WPX Energy, Inc.:企業の戦略・SWOT・財務情報
    WPX Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary WPX Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tetraphase Pharmaceuticals Inc (TTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a pharmaceutical company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory diseases cau …
  • Yoho Resources Inc. (YO)-石油・ガス分野:企業M&A・提携分析
    Summary Yoho Resources Inc. (Yoho) is an upstream oil and gas exploration company. The company carries out exploration, development and production of crude oil and natural gas liquid, and natural gas. The company has operations within the Western Canadian Sedimentary Basin focusing exploration activ …
  • Admedes GmbH:企業の戦略的SWOT分析
    Admedes GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • RWE AG (RWE):石油・ガス:M&Aディール及び事業提携情報
    Summary RWE AG (RWE) is an energy company. It has presence in the energy value chain, from lignite production and electricity generation, to energy trading and operation of distribution networks, and supply of electricity, gas and energy solutions. The company produces electricity using conventional …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Depuy Synthes Companies:企業の戦略・SWOT・財務分析
    Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report Summary Depuy Synthes Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • The Depository Trust & Clearing Corp:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Iberdrola SA (IBE)-エネルギー分野:企業M&A・提携分析
    Summary Iberdrola, S.A. (Iberdrola) is an electric utility. The company generates, trades, transmits, distributes and markets electricity and gas. It operates hydroelectric, thermal and nuclear power plants in Spain and other countries. The company also involved in the production of electricity from …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Fugro NV (FUR):電力:M&Aディール及び事業提携情報
    Summary Fugro NV (Fugro) is an integrated provider of geotechnical, survey, subsea and geosciences services. The company specializes in earth and engineering data services, from project preparation through to data acquisition, processing, analysis and interpretation, reporting and consulting. It ass …
  • Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析
    Summary Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life an …
  • Great Eastern Energy Corp Ltd (GEEC):企業の財務・戦略的SWOT分析
    Summary Great Eastern Energy Corp Ltd (GEECL), a subsidiary of YKM Holdings Pvt Ltd, is an oil and gas exploration and production company. The company carries out extraction and sale of coal bed methane coalbed methane gas. It operates upstream, midstream and downstream projects in Raniganj south bl …
  • Harvard Stem Cell Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Stem Cell Institute (HSCI) a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆